Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality

Overview of attention for article published in Proteome Science, July 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#25 of 211)
Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 56 Dimensions

Readers on

mendeley: 60 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

A METHOD FOR MEASURING A PROGNOSTIC MARKER IN PROSTATE CANCER OR IN BREAST CANCER

Application WO-2023285518-A1

World Intellectual Property Organisation (WIPO)

A METHOD FOR MEASURING A PROGNOSTIC MARKER IN PROSTATE CANCER

Application EP-4120187-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.